Doctor John R Nelson
California Cardiovascular Institute, Fresno (United States of America)
Cross-sectional analysis of demographic and clinical characteristics of patients using icosapent ethyl
Event: ESC Congress 2023
Topic: Lipid-Lowering Agents
Session: Hypertriglyceridemia treatment: CEPT, icosapent ethyl, and fibrates
